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226a Monday, March 2, 2009probe cantilever, while the other probe was attached to a rapid displacement
generator; the Ca2þ pulse was applied by rapid translation of a double-barreled
perfusion pipette (de Tombe, AJP, 2007). Activations were performed at long
(SL¼2.065 0.03 mm) and short (SL¼1.855 0.01; n¼5) length. As expected,
SL modulated maximum Ca2þ saturated force ~20%. Both the rate of force re-
development following a rapid release-restretch maneuver (kTr; ~26%) and
Ca2þ activated force development (kCa;~14%) were faster at the long SL.
In contrast, SL did not modulate any parameters of force relaxation following
rapid removal of activator Ca2þ. Our data suggest that length dependent myo-
filament activation in the heart may be the result of differential modulation of
activation dynamics in response to changes in sarcomere length.
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Skeletal tropomyosin, (Tm), is an a-helical coiled-coil which binds to actin, and
with troponin, regulates muscle contraction. We previously demonstrated that
a conserved Asp 137 in the hydrophobic interface produces a dynamic region
in the middle of Tm, and that this region is involved in the myosin dependent ac-
tivation of the thin filament at highCa2þ, (Sumida et. al. JBC283 2008). The cur-
rent work characterizes a long-range interaction between positions 137 and 190.
The thermodynamic properties of wild type (WT) Tm and two single mutants,
C190A and D137L, are compared with those of the double mutant, D137L/
C190A, using differential scanning calorimetry, (DSC), and circular dichroism,
(CD). CD measurements show that Ala 190 increases the fraction of helix un-
folding in the 40oC pre-transition, before the main transition. DSC measure-
ments support this finding, indicating a large enthalpic pre-transition,
(DH¼150kcal/mol), for the C190A mutant relative to D137L, D137L/
C190A, or WT, (average DH¼20kcal/mol). Additionally, Ala 190 increases
the DCp, (heat capacity), of Tm ~5 fold, reflecting an increase in solvent expo-
sure of hydrophobic residues in the pre-transition during unfolding.
Since the D137L/C190A and D137L mutants do not exhibit the large enthalpic
pre-transition observed for C190A, the Leu mutation at 137 must stabilize the
alanine effect observed for C190A mutation 77A˚ away. This demonstrates how
a locally dynamic region near 137 is able to produce global effects along the
thin filament, and in this manner provide the proper regulation of the myosin
dependent activation of the thin filament. This observation may also contribute
to our understanding about the manner in which single point mutations signif-
icantly affect function in cardio-myopathies such as FHC and DCM.
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The interaction between troponin T (TnT) and tropomyosin (Tm) is pivotal in
the Ca2þ-regulation of muscle contraction. It has been known for three de-
cades that TnT has two binding sites for Tm. The conserved middle and the
C-terminal regions of TnT each contain a Tm-binding site and both sites are
critical for the function of muscle thin filament. However, the precise locations
of the Tm-binding sites have not been identified. By mAb competition assays,
we located the middle region Tm-binding site of TnT in the beginning of the
conserved sequence. Previous data showed that deletion of the C-terminal 14
amino acids in TnT did not reduce Tm-binding. Cardiac TnT with a longer de-
letion of the C-terminal 28 amino acids also retained the C-terminal Tm-bind-
ing site as shown by its dominant cardiomyopathy phenotype that indicates
effective myofilament incorporation. In contrast, a truncation of slow TnT
deleting the C-terminal 83 amino acids due to a nonsense mutation significantly
lowered Tm-binding affinity and causes a recessive form of nemaline myopa-
thy. Considering the known crystal structure of partial troponin, we further
tested additional deletions to locate the C-terminal region Tm-binding site of
TnT in the beginning of the T2 segment. Different from the dominant C-termi-
nal truncation mutation of cardiac TnT, an error-splicing of the mutually ex-
clusive exon 16 and exon 17 in fast skeletal muscle TnT significantly lowered
Tm-binding affinity by deleting the C-terminal 28 amino acids and replacing it
with a long non-sense peptide. The suppression of potentially harmful effects of
the splicing error provides a mechanism to protect muscle function.
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Trout cardiac myofibrils are ~10-fold more sensitive to Caþ2 than those from
mammalian hearts when measured at the same temperature. It has been demon-strated that trout cardiac troponin C (ScTnC) has 2.3 fold the Ca2þ affinity of hu-
man cTnC and is responsible for a 2-fold increase in cardiac myofibril Caþ2 sen-
sitivity. The contributions of trout cardiac troponin I (ScTnI) to the Caþ2
sensitivity of the trout heart is currently unknown. The cDNA for ScTnI has
been cloned using RACE-PCR. Sequencing results indicate that ScTnI is 59%
and 56% identical to human cTnI and human skeletal troponin I, respectively, at
the amino acid level. Interestingly, ScTnI lacks the ~30-residue N-terminal se-
quencepresent inmammalian cTnI that contains twoproteinkinaseA(PKA) target
residues at positions 23 and 24. ScTnI has been expressed and the influence of it on
the Ca2þ activation of human cardiac troponin is currently being characterized us-
ing steady stateCa2þbinding assays and stoppedflowkinetic analysis. Thiswork is
supported by grants from the Natural Sciences and Engineering Research Council
of Canada (NSERC) and the Canadian Foundation for Innovation (CFI) to TEG.
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Wedemonstrated for the first time that PI3-kinase plays a role in the regulation of
smooth muscle contraction by controlling MLCP. The inhibition of PI3-kinase
markedly inhibited Ca2þ-induced contraction andGTPgS induced Ca2þ sensi-
tization ofa-toxin permeabilizedvascular smoothmuscle aswell asKþ-induced
contraction of intact vascular smooth muscle. The contractile inhibition was ac-
companied by the decrease in MLC phosphorylation and MBS phosphorylation
at Thr696 andThr853,which are responsible for the inhibition ofMLCPactivity.
On the other hand, the inhibition of PI3-kinase had no effect on MLCK activity.
These results suggest that PI3-kinase is involved in the regulation ofMLCP, thus
regulatingMLC phosphorylation. An Akt specific inhibitor, SH-6, had no effect
on the contraction, suggesting that Akt, one of themajor down-stream effecter of
the PI3-kinase pathway is not involved in thismechanism.MBSphosphorylation
at Thr853, a Rho kinase specific site, was decreased by the inhibition of PI3-ki-
nase even at rest, when Rho kinase is not activated. These results suggest that
PI3-kinase does not influence the MBS kinases, such as Rho kinase. In fact,
we found that the PI3-kinase inhibition activatedMBSphosphatase activity. Fur-
thermore,we found that PI3-kinase inhibition increasedMBSphsophorylation at
the PKG site, suggesting the activation of PKG pathway. Since the activation of
the cGMP/PKG pathway decreases MLC phosphorylation by activating MBS
phosphatase (Nakamura et al., 2007), our results suggest that PI3-kinase regu-
lates smooth muscle contraction by modulating the PKG pathway.
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Activation of the thin filament in striated muscle is a cooperative process requir-
ing both the binding of Ca2þ to troponin C (TnC) and the binding of myosin
crossbridges to actin. The aim of this studywas to assess the role of TnCdomains
in the crossbridge-mediated activation of rabbit skeletalmusclemyofibrils in the
absence of Ca2þ. Activation ofmyofibrillar ATPasewas produced by addition of
varying concentrations of myosin S1modified byN-ethylmaleimide (NEM-S1),
which facilitates crossbridge cycling by forcing tropomyosin into the open posi-
tion on the filament. Comparisons were made of native myofibrils, myofibrils
from which TnC was extracted, and myofibrils reconstituted with either a TnC
mutant (TnC48-82) in which Ca
2þ activation was blocked by a disulfide bond
in theN-terminal domain (Grabarek, et al,Nature, 345:132,1990) or a proteolytic
fragment of TnC (TR2C) lacking the N-terminal Ca2þ- binding domain (Gra-
barek, et al, J. Biol. Chem. 265:13121, 1981). The ATPase activity of native
myofibrils was increased ~170% by the addition of NEM-S1 (2-4mM). Follow-
ing extraction of TnC the addition of the same concentrations of NEM-S1
produced ~60% activation. In both cases higher concentrations of NEM-S1 pro-
duced no further increase in activation. With the addition of either TnC48-82 or
TR2C the degree of activation was higher (70-100%), but required higher
NEM-S1 concentrations (4-8mM). These results suggest that both domains of
TnC play a role in facilitating optimal crossbridge-mediated activation of the
thin filament, presumably by providing alternative binding sites for troponin I.
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Regulation of contraction in striated muscles requires a semi-independent
movement of various domains of the tropomyosin-troponin (TmTn) complex
